• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Novo Nordisk A>Novo Nordisk A/S ADR

Novo Nordisk A/S ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. EUROPE MARKETS: Aveva Sinks; Novo Nordisk Climbs: Europe's Big Stock Movers

    EUROPE MARKETS: Aveva Sinks; Novo Nordisk Climbs: Europe's Big Stock Movers

  2. UPDATE: Aveva sinks; Novo Nordisk climbs: Europe's big stock movers

    UPDATE: Aveva sinks; Novo Nordisk climbs: Europe's big stock movers

  3. ADR Shares End Lower; Novo Nordisk Shares Trade Actively

    ADR Shares End Lower; Novo Nordisk Shares Trade Actively

  4. UPDATE: Roche climbs on deal; banks higher: Europe's stock moves

    UPDATE: Roche climbs on deal; banks higher: Europe's stock moves

  5. Roche climbs on deal, banks higher: Europe movers

    Roche climbs on deal, banks higher: Europe movers

  6. Moats and Growth Drivers Look Solid for Post-Split Baxter

    Focus remains on hemophilia competition, but Baxter's comprehensive product portfolios are unmatched.

  7. Makings of a Wide Moat in Diabetes Care

    Novel products will allow drug firms to achieve price premiums on diabetes drugs in the U.S. and at least retain level pricing internationally.

  8. Strong Pipeline Helps Protect Baxter's Wide Moat From Competition

    The diversified health-care firm remains remarkably profitable in tough industries.

  9. Novo Nordisk Has One of the Widest Moats in Health Care

    Morningstar StockInvestor editor Matt Coffina explains why he recently purchased Novo Nordisk for StockInvestor's real-money Hare portfolio.

  10. Wide Moats, Positive Moat Trends, Exemplary Stewardship

    Morningstar StockInvestor editor Matt Coffina highlights three of the highest-quality companies we cover.

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.